ARTIVION, INC. Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt
ARTIVION, INC. (AORT) reported Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt of $16.43 million for the 12-month period ending 2020-12-31, per its 10-K filed 2023-02-23.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt · last filed 2023-02-23
- ARTIVION, INC. adjustments to additional paid in capital, equity component of convertible debt for the quarter ending 2020-12-31 was $0.00.
- ARTIVION, INC. adjustments to additional paid in capital, equity component of convertible debt for the quarter ending 2020-09-30 was $0.00.
- ARTIVION, INC. adjustments to additional paid in capital, equity component of convertible debt for the quarter ending 2020-06-30 was $16.43M.
- ARTIVION, INC. adjustments to additional paid in capital, equity component of convertible debt for fiscal 2020 was $16.43M.
| Period end | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt 3 month | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt 6 month | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt 9 month | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $16.43M derived: sum of 3 quarters · filed 2023-02-23 | $16.43M 10-K · filed 2023-02-23 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $16.43M derived: sum of 2 quarters · filed 2021-11-05 | $16.43M 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $16.43M 10-Q · filed 2021-07-30 | $16.43M 10-Q · filed 2021-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |